Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Cancer Discovery
|
June 3, 2023
Patient-Centric Approaches for Phase I Combination Trials Come on Stage
Alberto Hernando-Calvo, Elena Garralda
Breast Cancer Research and Treatment
|
October 8, 2021
Novel classes of immunotherapy for breast cancer
Alberto Hernando-Calvo, David W Cescon, Philippe L Bedard
Cancer Treatment Reviews
|
May 19, 2024
Agnostic drug development revisited
Alberto Hernando-Calvo, Alice Rossi, Maria Vieito, et al.
Cancer Treatment Reviews
|
May 31, 2024
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
Pablo Jiménez-Labaig, Antonio Rullan, Alberto Hernando-Calvo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2022
Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials
Abdulazeez Salawu, Alberto Hernando-Calvo, Rachel Y Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 9, 2022
A risk stratification model for toxicities in phase 1 immunotherapy trials
Alberto Hernando-Calvo, Abdulazeez Salawu, Rachel Y Chen, et al.
Cancer Treatment Reviews
|
October 9, 2022
Response to "Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias"
Guillermo Villacampa, Alberto Hernando-Calvo, Roger Berché, et al.
Oncotarget
|
June 17, 2025
Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment
Alberto Hernando-Calvo, Razelle Kurzrock, Nadia Saoudi Gonzalez, et al.
Frontiers in Immunology
|
November 7, 2025
Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies
Greta Catani, Daniel Morchón-Araujo, Oriol Mirallas, et al.
Cancer Treatment Reviews
|
May 2, 2024
Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives
Pablo Jiménez-Labaig, Antonio Rullan, Irene Braña, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Cancer Discovery
|
June 3, 2023
Patient-Centric Approaches for Phase I Combination Trials Come on Stage
Alberto Hernando-Calvo, Elena Garralda
Breast Cancer Research and Treatment
|
October 8, 2021
Novel classes of immunotherapy for breast cancer
Alberto Hernando-Calvo, David W Cescon, Philippe L Bedard
Cancer Treatment Reviews
|
May 19, 2024
Agnostic drug development revisited
Alberto Hernando-Calvo, Alice Rossi, Maria Vieito, et al.
Cancer Treatment Reviews
|
May 31, 2024
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
Pablo Jiménez-Labaig, Antonio Rullan, Alberto Hernando-Calvo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2022
Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials
Abdulazeez Salawu, Alberto Hernando-Calvo, Rachel Y Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 9, 2022
A risk stratification model for toxicities in phase 1 immunotherapy trials
Alberto Hernando-Calvo, Abdulazeez Salawu, Rachel Y Chen, et al.
Cancer Treatment Reviews
|
October 9, 2022
Response to "Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias"
Guillermo Villacampa, Alberto Hernando-Calvo, Roger Berché, et al.
Oncotarget
|
June 17, 2025
Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment
Alberto Hernando-Calvo, Razelle Kurzrock, Nadia Saoudi Gonzalez, et al.
Frontiers in Immunology
|
November 7, 2025
Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies
Greta Catani, Daniel Morchón-Araujo, Oriol Mirallas, et al.
Cancer Treatment Reviews
|
May 2, 2024
Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives
Pablo Jiménez-Labaig, Antonio Rullan, Irene Braña, et al.
Page
of 4